Cordani David's Form 4 filing
Cigna Group (CI) · filed Feb 28, 2023
- Accession no.
- 0001225208-23-002993
- Filed
- Feb 28, 2023
- Trade date
- Feb 24-27, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $5.92M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cordani DavidCIK 0001318751 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2023 | Common Stock, $.01 Par Value | AGrant or awardAcquired | +37,549 | $0.00 | $0 | 160,351 | Direct | |
| Feb 24, 2023 | Common Stock, $.01 Par Value | FTax withholdingDisposed | −2,306 | $294.27 | −$678,586.62 | 158,045 | Direct | |
| Feb 24, 2023 | Common Stock, $.01 Par Value | FTax withholdingDisposed | −17,401 | $294.27 | −$5,120,592.27 | 140,644 | Direct | |
| Feb 27, 2023 | Common Stock, $.01 Par Value | SSaleDisposed | −20,148 | $294.06 | −$5,924,720.88 | 120,496 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.